KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
KBIO was delisted on the 16th of December, 2015.
0 hedge funds and large institutions have $0 invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $65K → $0 (-$65K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
-$65K |
KBIO Hedge Fund Activity: Q2 2016 in Review
0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q2 2016, worth a combined $0 — down 100% from $65K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KBIO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $65K sold.
- 0 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q2 2016, down from 1 in Q1 2016.
- Funds reported $0 of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q2 2016 and 1 closed out, a net change of -1 holder.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) seller in Q2 2016 was California Public Employees Retirement System, an estimated $65K sold.
Based on aggregated 13F filings for Q2 2016.